Tiny antibodies hold big promise for cancer treatment
Using antibodies derived from alpacas, a University of Kentucky research team has developed a tool that could lead to new therapies to stop the growth of several types of cancer.
Using antibodies derived from alpacas, a University of Kentucky research team has developed a tool that could lead to new therapies to stop the growth of several types of cancer.
Bio & Medicine
Aug 10, 2023
0
30
Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset ...
Cell & Microbiology
Aug 3, 2023
0
14
Schistosomiasis, a parasitic disease that causes organ damage and death, affected more than 250 million people worldwide in 2021, according to the World Health Organization.
Ecology
Jul 13, 2023
0
1
The World Health Organization lists bacteria that are resistant to antibiotics as one of the top 10 global health threats. Therefore, researchers are looking for new antibiotics to counter this resistance. Adéla Melcrová, ...
Cell & Microbiology
Jul 13, 2023
0
12
Induced pluripotent stem (iPS) cells have a great impact on biology and medicine, and they are expected to improve regenerative medicine. Since 2014, when a sheet of retinal pigment epithelial cells derived from iPS cells ...
Cell & Microbiology
Jul 3, 2023
0
7
Researchers from the University of Edinburgh, Scotland, and the University of Cantabria, Spain, have teamed up to develop an AI trained to discover senolytic medicinal chemistry in familiar compounds.
University of Queensland researchers have shown Australian tobacco plants could be used as 'biofactories' to manufacture medicines on a large scale.
Biotechnology
Jun 1, 2023
0
12
Psilocybin is a hallucinogenic compound found in about 200 mushroom species, including the liberty cap (Psilocybe semilanceata). For millennia, our ancestors have known and used this substance, and in recent years, it has ...
Biochemistry
May 2, 2023
1
79
A team of researchers from the University of California, Irvine, have revealed the first crystal structures of the receptor-binding domain of botulinum neurotoxin E (BoNT/E) in complex with its human neuronal receptors, synaptic ...
Cell & Microbiology
Apr 27, 2023
0
367
A new type of drug could provide a way to treat multidrug-resistant bacteria, according to a study published in Nature Communications. Instead of targeting the bacteria directly, the drug blocks key toxins involved in the ...
Cell & Microbiology
Apr 18, 2023
1
67